Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Filter By:

Search by Keyword (disease, investigator, treatment name):

Immune Cells and Immune Factors from Healthy Donors or Transplant Recipients

Disease Sites: Not Available

Phase: N/A

Investigator: Engelhardt, Brian

NCTID:

Protocol No: VICCCTT1645

MRI-Ultrasound Fusion Targeted Prostate Biopsies - Quality Control & Performance Improvement

Prostate

Disease Sites: Prostate

Phase: N/A

Investigator: Barocas, Daniel

NCTID:

Protocol No: VICCURO1680

Prospective Observational Trial of an Absorbable Hydrogel Spacer in Prostate Cancer Radiotherapy

Prostate

Disease Sites: Prostate

Phase: N/A

Investigator: Kirschner, Austin

NCTID:

Protocol No: VICCURO16112

Ocular Tumor Tissue Acquisition to Study Biologic Correlates of Disease

Multiple Cancer Types

Disease Sites: Pediatrics, Retinoblastoma (Pediatrics)

Phase: N/A

Investigator: Daniels, Anthony

NCTID:

Protocol No: VICCPED16115

Prospective Validation of Prostate Biomarkers for Repeat Biopsy: The PRIORITY Study

Prostate

Disease Sites: Prostate

Phase: N/A

Investigator: Chang, Sam

NCTID:

Protocol No: VICCURO1734

Using Biomarkers and Imaging in Fungal Regions to Improve Lung Cancer Diagnosis

Lung

Disease Sites: Lung

Phase: N/A

Investigator: Grogan, Eric

NCTID:

Protocol No: VICCTHO1764

Chemotherapy Levels in the Blood of Patients with Retinoblastoma

Retinoblastoma (Pediatrics)

Disease Sites: Retinoblastoma (Pediatrics)

Phase: N/A

Investigator: Daniels, Anthony

NCTID:

Protocol No: VICCREACH1792

Chemotherapy Levels in the Eyes of Patients with Retinoblastoma

Retinoblastoma (Pediatrics)

Disease Sites: Retinoblastoma (Pediatrics)

Phase: N/A

Investigator: Daniels, Anthony

NCTID:

Protocol No: VICCREACH17106

Developing Evidence-Based Criteria for Initiating Treatment for Neurofibromatosis Type 1 Associated Optic Pathway Glioma

Multiple Cancer Types

Disease Sites: Neuro-Oncology, Pediatrics

Phase: N/A

Investigator: Esbenshade, Adam

NCTID:

Protocol No: VICCPED17108

Optimization of Cancer Therapy Using Immune Effector Cells

Hematologic

Disease Sites: Hematologic

Phase: N/A

Investigator: Oluwole, Olalekan

NCTID:

Protocol No: VICCCTT1834

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)